TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GERN

Geron Corporation

Healthcare · Biotechnology

1.30$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement GERN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+3,054.5% -83.1% -82.7% +0.1% -56.8% -45.0% +450.6% -57.2% -60.2% +32,386.9% +138.8%
+7.6% +53.5% -42.6% +50.8% +208.6% +27.5% -98.4% +10.9% +14,155.8% -99.0% +277.8%
-131.8% -10,925.9% -57.2% -60.2% +31,857.0% +136.5%
-13.9% +1.2% -38.9% +21.7% +287.7% -1.1% +66.5% +11.4% +30.9% -17.0% -28.9%
+6.2% +5.4% +2.8% -3.0% +11.7% +22.9% +15.5% +47.1% +58.5% +110.8% +9.3%
-4.9% +3.3% -17.6% +6.0% +127.0% -62.8% +325.6% +20.6% +39.6% +28.5% -6.6%
+7.3% -5.7% -7.2% -100.0% +392.1% +84.0% +20.8% +122.6% +76.5%
-64,310.9%
-8.6% +3,371.9% +20.6% +202.7% -223.2% -117.9%
-64,310.9%
-3,906.4%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?